LumiraDx Shares Owned By Institutions vs. Price To Sales

LMDXDelisted Stock  USD 0.42  0.02  4.55%   
Based on the key profitability measurements obtained from LumiraDx's financial statements, LumiraDx may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess LumiraDx's ability to earn profits and add value for shareholders.
For LumiraDx profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LumiraDx to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LumiraDx utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LumiraDx's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LumiraDx over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Please note, there is a significant difference between LumiraDx's value and its price as these two are different measures arrived at by different means. Investors typically determine if LumiraDx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LumiraDx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

LumiraDx Price To Sales vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining LumiraDx's current stock value. Our valuation model uses many indicators to compare LumiraDx value to that of its competitors to determine the firm's financial worth.
LumiraDx is rated below average in shares owned by institutions category among its peers. It is rated fifth overall in price to sales category among its peers fabricating about  0.08  of Price To Sales per Shares Owned By Institutions. The ratio of Shares Owned By Institutions to Price To Sales for LumiraDx is roughly  12.80 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LumiraDx's earnings, one of the primary drivers of an investment's value.

LumiraDx Price To Sales vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

LumiraDx

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
25.26 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

LumiraDx

P/S

 = 

MV Per Share

Revenue Per Share

 = 
1.97 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

LumiraDx Price To Sales Comparison

LumiraDx is currently under evaluation in price to sales category among its peers.

LumiraDx Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in LumiraDx, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LumiraDx will eventually generate negative long term returns. The profitability progress is the general direction of LumiraDx's change in net profit over the period of time. It can combine multiple indicators of LumiraDx, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
LumiraDx Limited operates as a point of care diagnostics company. The company was founded in 2014 and is headquartered in London, the United Kingdom. Lumiradx is traded on NASDAQ Exchange in the United States.

LumiraDx Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on LumiraDx. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LumiraDx position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LumiraDx's important profitability drivers and their relationship over time.

Use LumiraDx in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LumiraDx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LumiraDx will appreciate offsetting losses from the drop in the long position's value.

LumiraDx Pair Trading

LumiraDx Pair Trading Analysis

The ability to find closely correlated positions to LumiraDx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LumiraDx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LumiraDx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LumiraDx to buy it.
The correlation of LumiraDx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LumiraDx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LumiraDx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LumiraDx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your LumiraDx position

In addition to having LumiraDx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Funds Thematic Idea Now

World Allocation Funds
World Allocation Funds Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in LumiraDx Stock

If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world